Priyanshu Pharmaceutical Private Limited
Founded in 2014 and headquartered in Jharkhand, India.
2014 | Dhanbad, Jharkhand (India) | Active
Priyanshu Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 0.80 M
About Priyanshu Pharmaceutical
Priyanshu Pharmaceutical Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2014 and has a history of Ten years and 11 months. Its registered office is in Dhanbad, Jharkhand.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Vivekanand Singh and Sumit Singh serve as directors at the Company.
Company Details
- Location Dhanbad, Jharkhand
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397JH2014PTC002103
- Company No.
002103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2014
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Pharma
Who are the key members and board of directors at Priyanshu Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivekanand Singh  | Director | 31-Mar-2014 | Current |
| Sumit Singh | Director | 31-Mar-2014 | Current |
Financial Performance of Priyanshu Pharmaceutical.
Enhance accessibility to Priyanshu Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Priyanshu Pharmaceutical?
In 2016, Priyanshu Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Planet Interior & Construction Private Limited
Sumit Singh is a mutual person
Charges (Loans)
Open Charges
₹0.80 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Allahabad Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Sep 2015 | Allahabad Bank | ₹0.80 M | Open |
How Many Employees Work at Priyanshu Pharmaceutical?
Unlock and access historical data on people associated with Priyanshu Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Priyanshu Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Priyanshu Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.